Overview

The Care and Prevention in the United States (CAPUS) Demonstration Project is a 3-year cross-agency demonstration project led by the Centers for Disease Control and Prevention (CDC). The purpose of the project is to reduce HIV and AIDS-related morbidity and mortality among racial and ethnic minorities living in the United States. The primary goals of the project are to:

Increase the proportion of racial and ethnic minorities with HIV who have diagnosed infection by expanding and improving HIV testing capacity, and

These two goals are to be achieved by addressing social, economic, clinical, and structural factors influencing HIV health outcomes.

Advertisement

This project directly supports the NHAS goals by improving program planning and implementation to:

Reduce new HIV infections,

Increase access to care and improve health outcomes for people living with HIV,

Reduce HIV-related disparities and health inequities, and

Achieve a more coordinated national response to the HIV epidemic in the United States.

Lessons learned from the CAPUS demonstration project will help to further inform how federal agencies can best work with one another, with health departments, and with communities to reach the NHAS goals across the country.

Cross-Agency Collaboration

In keeping with the spirit and goals of the NHAS, and in recognition of the complex, interrelated, and multi-sectorial nature of the goals, a multi-agency federal partnership provides federal leadership for the project. CDC is the lead federal agency and works closely with the Office of the Assistant Secretary for Health (Office of HIV/AIDS and Infectious Disease Policy, Office of Minority Health, Office on Women's Health), and the Health Resources and Services Administration (both the HIV/AIDS Bureau and the Bureau of Primary Health Care), and the Substance Abuse and Mental Health Services Administration. Together, this federal partnership oversees all stages of the project.

Grantees

Because of the high HIV disease burden among racial and ethnic minority populations, the disproportionate rate of AIDS diagnoses and associated mortality, and the pervasive effect of social and structural determinants of health, eligibility for funding was limited to 18 state health departments in the United States. The 18 eligible jurisdictions were selected based upon the following three criteria:

Burden of illness. Jurisdictions that had greater than 5,000 HIV cases among African Americans and Latinos were included.

Disproportionately affected areas. Jurisdictions that had an AIDS diagnosis rate of over 6 per 100,000 in 2010 were included. This focus on disproportionately affected geographic areas is in concordance with the NHAS focus on decreasing health disparities.

Social determinants of health. Those jurisdictions with a teen birth rate over 25 per 1,000 were included. This indicator allowed a focus on jurisdictions with underlying social and economic factors that impede HIV prevention and care.

Through a competitive application and review process, the following eight health departments were awarded funding:

Georgia Department of Public Health

Illinois Department of Public Health

Louisiana State Department of Health and Hospitals

Mississippi State Department of Health

Missouri Department of Health and Senior Services

North Carolina State Department of Health and Human Services

Tennessee State Department of Health

Virginia State Department of Health

Funding

CAPUS is supported by funds from the HHS Secretary's Minority AIDS Initiative Fund. In FY 2012, $14.2 million was awarded for Year 1 activities beginning September 2012. The total projected estimated funding for the entire 3 year project period is $44.2 million.

Project Phases

There are two phases of the project:

Phase 1 (Six-month development phase): Health departments collaborate with local and federal partners to finalize the components of their demonstration project.

Phase 2 (Implementation & Evaluation phase): Following the approval of work plans, health departments will begin implementing and evaluating their demonstration projects.

Program performance will primarily be assessed using impact and outcome measures that can be calculated using existing, HHS-supported data systems (e.g., HIV disease surveillance). Guidance on program monitoring and evaluation (M&E) and performance measures will be provided by the federal partners on an ongoing basis throughout the project period. CDC and other federal partners will work collaboratively with grantees to determine the most appropriate measures for routine reporting.

(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Beforeadding your comment, please read TheBody.com's Comment Policy.)

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.